ADDUS HOMECARE CORP (ADUS)

US0067391062 - Common Stock

98.2  -0.21 (-0.21%)

After market: 98.2 0 (0%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to ADUS. ADUS was compared to 117 industry peers in the Health Care Providers & Services industry. ADUS scores excellent points on both the profitability and health parts. This is a solid base for a good stock. ADUS is not valued too expensively and it also shows a decent growth rate. These ratings would make ADUS suitable for quality investing!



8

1. Profitability

1.1 Basic Checks

ADUS had positive earnings in the past year.
ADUS had a positive operating cash flow in the past year.
Each year in the past 5 years ADUS has been profitable.
In the past 5 years ADUS always reported a positive cash flow from operatings.

1.2 Ratios

Looking at the Return On Assets, with a value of 6.10%, ADUS belongs to the top of the industry, outperforming 87.07% of the companies in the same industry.
With a decent Return On Equity value of 8.85%, ADUS is doing good in the industry, outperforming 72.41% of the companies in the same industry.
ADUS has a Return On Invested Capital of 8.10%. This is amongst the best in the industry. ADUS outperforms 80.17% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ADUS is in line with the industry average of 8.60%.
The last Return On Invested Capital (8.10%) for ADUS is above the 3 year average (7.41%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.1%
ROE 8.85%
ROIC 8.1%
ROA(3y)5.26%
ROA(5y)4.69%
ROE(3y)7.99%
ROE(5y)7.13%
ROIC(3y)7.41%
ROIC(5y)6.45%

1.3 Margins

ADUS has a better Profit Margin (5.91%) than 88.79% of its industry peers.
In the last couple of years the Profit Margin of ADUS has grown nicely.
The Operating Margin of ADUS (8.77%) is better than 84.48% of its industry peers.
In the last couple of years the Operating Margin of ADUS has grown nicely.
Looking at the Gross Margin, with a value of 32.24%, ADUS is in line with its industry, outperforming 57.76% of the companies in the same industry.
ADUS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 8.77%
PM (TTM) 5.91%
GM 32.24%
OM growth 3Y9.99%
OM growth 5Y14.67%
PM growth 3Y10.91%
PM growth 5Y13.22%
GM growth 3Y3.16%
GM growth 5Y4.03%

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ADUS is destroying value.
The number of shares outstanding for ADUS has been increased compared to 1 year ago.
The number of shares outstanding for ADUS has been increased compared to 5 years ago.
Compared to 1 year ago, ADUS has an improved debt to assets ratio.

2.2 Solvency

ADUS has an Altman-Z score of 4.83. This indicates that ADUS is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of ADUS (4.83) is better than 87.07% of its industry peers.
The Debt to FCF ratio of ADUS is 1.21, which is an excellent value as it means it would take ADUS, only 1.21 years of fcf income to pay off all of its debts.
ADUS has a Debt to FCF ratio of 1.21. This is amongst the best in the industry. ADUS outperforms 89.66% of its industry peers.
A Debt/Equity ratio of 0.18 indicates that ADUS is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.18, ADUS is in the better half of the industry, outperforming 73.28% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 1.21
Altman-Z 4.83
ROIC/WACC0.9
WACC8.99%

2.3 Liquidity

ADUS has a Current Ratio of 1.38. This is a normal value and indicates that ADUS is financially healthy and should not expect problems in meeting its short term obligations.
ADUS's Current ratio of 1.38 is in line compared to the rest of the industry. ADUS outperforms 49.14% of its industry peers.
A Quick Ratio of 1.38 indicates that ADUS should not have too much problems paying its short term obligations.
ADUS's Quick ratio of 1.38 is in line compared to the rest of the industry. ADUS outperforms 57.76% of its industry peers.
The current and quick ratio evaluation for ADUS is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 1.38

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 20.91% over the past year.
Measured over the past years, ADUS shows a quite strong growth in Earnings Per Share. The EPS has been growing by 18.26% on average per year.
Looking at the last year, ADUS shows a quite strong growth in Revenue. The Revenue has grown by 11.31% in the last year.
ADUS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.43% yearly.
EPS 1Y (TTM)20.91%
EPS 3Y13.56%
EPS 5Y18.26%
EPS growth Q2Q18.92%
Revenue 1Y (TTM)11.31%
Revenue growth 3Y11.45%
Revenue growth 5Y15.43%
Revenue growth Q2Q11.86%

3.2 Future

ADUS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.77% yearly.
ADUS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.74% yearly.
EPS Next Y8.22%
EPS Next 2Y9.01%
EPS Next 3Y10.77%
EPS Next 5YN/A
Revenue Next Year8.26%
Revenue Next 2Y6.9%
Revenue Next 3Y6.74%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 21.77 indicates a rather expensive valuation of ADUS.
70.69% of the companies in the same industry are more expensive than ADUS, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of ADUS to the average of the S&P500 Index (28.28), we can say ADUS is valued slightly cheaper.
With a Price/Forward Earnings ratio of 20.12, ADUS is valued on the expensive side.
Based on the Price/Forward Earnings ratio, ADUS is valued a bit cheaper than 67.24% of the companies in the same industry.
ADUS's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 20.88.
Industry RankSector Rank
PE 21.77
Fwd PE 20.12

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ADUS indicates a somewhat cheap valuation: ADUS is cheaper than 62.07% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ADUS indicates a rather cheap valuation: ADUS is cheaper than 81.03% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 15.5
EV/EBITDA 15.48

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ADUS does not grow enough to justify the current Price/Earnings ratio.
ADUS has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.65
PEG (5Y)1.19
EPS Next 2Y9.01%
EPS Next 3Y10.77%

0

5. Dividend

5.1 Amount

ADUS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ADDUS HOMECARE CORP

NASDAQ:ADUS (5/3/2024, 7:00:00 PM)

After market: 98.2 0 (0%)

98.2

-0.21 (-0.21%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.59B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 21.77
Fwd PE 20.12
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)2.65
PEG (5Y)1.19
Profitability
Industry RankSector Rank
ROA 6.1%
ROE 8.85%
ROCE
ROIC
ROICexc
ROICexgc
OM 8.77%
PM (TTM) 5.91%
GM 32.24%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.03
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.38
Quick Ratio 1.38
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)20.91%
EPS 3Y13.56%
EPS 5Y
EPS growth Q2Q
EPS Next Y8.22%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)11.31%
Revenue growth 3Y11.45%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y